Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis - Sîrbulescu - 2024

Wiley & Sons·Jul 5

This story is reported by Wiley & Sons. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Engineering neuroimmune regulation: biomaterial and nanotechnology platforms for neuropathology diagnosis and targeted immunomodulation

Frontiers·Jan 9

2

New B-cell therapy eases disease severity, delays onset: Study

ALS News Today·Jul 19

3

Mesenchymal stem cells and the central nervous system: historical perspectives and future directions

Frontiers·Jan 29

4

Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial

Nature·May 8

5

Mesenchymal stromal cell therapy: Progress to date and future outlook

ScienceDirect.com·Jun 4

6

Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential

Nature·Oct 14

7

Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications

Frontiers·Feb 9

8

Stem cell-based therapy for human diseases - Signal Transduction and Targeted Therapy

Nature·Aug 6